Hospital-wide Incidence, Clinical Characteristics and Outcomes of ARDS
A Multicenter Prospective Cohort Study of Hospital-wide Incidence, Clinical Characteristics and Outcomes of ARDS - The NITWA ARDS Study
1 other identifier
observational
9,999
3 countries
4
Brief Summary
The Acute Respiratory Distress Syndrome (ARDS) impacts one of every four patients requiring mechanical ventilation for respiratory support and carries a mortality rate of 40%. To diagnose ARDS, doctors currently use the Berlin definition, that requires chest radiographs and analysis of oxygenation in the blood (arterial blood gas). These tests are not available in areas of the world with constrained resources and may be unnecessarily invasive. A modification of the Berlin definition, using ultrasound and pulse oximetry (a small device that measures oxygen level non-invasively by clipping to the body, typically a finger), has been recently developed and tested in Kigali, Rwanda. This study will try to confirm the validity of the Kigali modification initially in Boston and Toronto and subsequently in other hospitals worldwide. If confirmed, this new definition could allow for faster recognition and potentially improved treatment of patients with ARDS and facilitate studies worldwide. The purposes of this study are:
- 1.To describe clinical characteristics and outcomes of patients diagnosed with ARDS according to the Berlin and Kigali definitions;
- 2.To determine how well chest radiograph and ultrasound of the chest are able to define ARDS, in comparison to chest computer tomography (CT).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2018
Longer than P75 for all trials
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 17, 2018
CompletedFirst Posted
Study publicly available on registry
June 6, 2018
CompletedStudy Start
First participant enrolled
October 24, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 5, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 15, 2023
CompletedMay 11, 2023
May 1, 2023
4.5 years
May 17, 2018
May 10, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Hospital-wide incidence of ARDS
ARDS incidence will be calculated as the number of patients fulfilling ARDS (Berlin or Kigali) during the first first 7 days of hospital admission divided by the total adult hospital admissions during the study period.
Up to 7 days
Secondary Outcomes (1)
Sensitivity and specificity for bilateral opacities of both chest radiographs and chest ultrasound done within 12 hours as compared to the reference standard CT scans
Over the first 7 days of admission
Interventions
Estimation of hospital-wide incidence of ARDS defined according to both the Berlin definition and the Kigali modification. * To describe clinical characteristics and outcomes for these patients. * To analyze the prognosis and time course of patients who initially meet criteria for Kigali-defined ARDS and subsequently progress to Berlin-defined ARDS. For the subset of patients who have chest CT, to determine the sensitivity and specificity for bilateral opacities of both chest radiographs and chest ultrasound done within 12 hours as compared to the reference standard CT scans.
Eligibility Criteria
All adults admitted to the hospital during either of two one-week study periods (winter and summer)
You may qualify if:
- Hospital admission during the study period
- Age ≥ 18 years old
- New onset of hypoxemia (SpO2 \< 90% or use of any supplemental oxygen) or, for patients on home O2 treatment, higher than baseline O2 flow needed during the first 7 days of hospitalization.
You may not qualify if:
- Patient in the Emergency Department but not formally admitted to the hospital
- Patient admitted in PACU
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
University Health Network
Toronto, Ontario, M5T2S8, Canada
AOU Citta' della Salute e Della Scienza - Molinette
Torino, Italy
Ospedale San Giovanni Bosco
Torino, Italy
Related Publications (1)
Riviello ED, Kiviri W, Twagirumugabe T, Mueller A, Banner-Goodspeed VM, Officer L, Novack V, Mutumwinka M, Talmor DS, Fowler RA. Hospital Incidence and Outcomes of the Acute Respiratory Distress Syndrome Using the Kigali Modification of the Berlin Definition. Am J Respir Crit Care Med. 2016 Jan 1;193(1):52-9. doi: 10.1164/rccm.201503-0584OC.
PMID: 26352116BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alberto Goffi, MD
University Health Network, Toronto
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
May 17, 2018
First Posted
June 6, 2018
Study Start
October 24, 2018
Primary Completion
May 5, 2023
Study Completion
October 15, 2023
Last Updated
May 11, 2023
Record last verified: 2023-05